CD19-targeting CAR T Cells in Relapsed or Refractory CD19 Positive B-cell Malignancies

Clinical trial NCT03559439 · UNKNOWN

Trial details

NCT number: NCT03559439
Sponsor: Shanghai Tong Ren Hospital
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

B-cell Malignancy B-cell Lymphoma B-Cell Acute Lymphoblastic Leukaemia

Start date: 2018-04-24
Primary completion: 2021-11-30
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.